Skip to content

CIK 0001178879

FOLD AMICUS THERAPEUTICS, INC.

Insider trading from SEC Form 4. Last filing Mar 4, 2026.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
14
with a Form 4 at this company

Signals

Open-market buys and sells at AMICUS THERAPEUTICS, INC., scored.

ScoreInsiderValueHoldingsPrice contextFiled
19WeakBradley L Campbell
President and CEO
sell
$323k
22,500 shares
-2%-
15WeakBradley L Campbell
President and CEO
sell
$1.1M
75,000 shares
-7%-
18WeakDavid Michael Clark
Chief People Officer
sell
$363k
25,642 shares
-9%-
17WeakDavid Michael Clark
Chief People Officer
sell
$282k
25,643 shares
-9%-
21WeakBradley L Campbell
President and CEO
sell
$846k
77,926 shares
-6%-
16WeakBradley L Campbell
President and CEO
sell
$146k
14,587 shares
-1%-
24WeakEllen Rosenberg
Chief Legal Officer
sell
$958k
95,621 shares
-18%-
16WeakBradley L Campbell
President and CEO
sell
$147k
14,587 shares
-1%-
23WeakDavid Michael Clark
Chief People Officer
sell
$259k
25,643 shares
-8%-
22WeakJeff Castelli
Chief Development Officer
sell
$774k
76,158 shares
-15%-
8WeakDavid Michael Clark
Chief People Officer
sell
$244k
25,643 shares
-7%-
0WeakBradley L Campbell
President and CEO
sell
$4,000
400 shares
-0%-
0WeakBradley L Campbell
President and CEO
sell
$75k
7,500 shares
-1%-
0WeakBradley L Campbell
President and CEO
sell
$99k
7,901 shares
-1%-
0WeakBradley L Campbell
President and CEO
sell
$86k
7,500 shares
-1%-

Planned sales

Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales

FiledSellerSharesValueSale datePast 3 months
Dec 2, 2024 BRADLEY CAMPBELL
Director, Officer
7,500
0.00% of outstanding
$75kDec 2, 2024$352k
Nov 6, 2024 BRADLEY CAMPBELL
Director, Officer
7,901
0.00% of outstanding
$93kNov 6, 2024$253k
Nov 1, 2024 BRADLEY CAMPBELL
Director, Officer
7,500
0.00% of outstanding
$86kNov 1, 2024$167k

Transactions

The last 100 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Mar 2, 2026Bradley L Campbell
President and CEO
SOpen-market sale
Common Stock10b5-1
-22,500$14.35$323k998,680Mar 4, 2026
Jan 20, 2026Bradley L Campbell
President and CEO
MOption exercise
Common Stock10b5-1
+75,000$6.10$458k1,096,180Jan 22, 2026
Jan 20, 2026Bradley L Campbell
President and CEO
SOpen-market sale
Common Stock10b5-1
-75,000$14.31$1.1M1,021,180Jan 22, 2026
Jan 20, 2026Bradley L Campbell
President and CEO
MOption exercise
Stock Options (right to buy)derivative10b5-1
-75,000$0.00$00Jan 22, 2026
Jan 2, 2026Samantha Prout
Chief Accounting Officer
FTax withholding
Common Stock
-3,443$14.27$49k138,191Jan 6, 2026
Jan 2, 2026Ellen Rosenberg
Chief Legal Officer
FTax withholding
Common Stock
-13,426$14.27$192k494,284Jan 6, 2026
Jan 2, 2026David Michael Clark
Chief People Officer
FTax withholding
Common Stock
-5,381$14.27$77k240,309Jan 6, 2026
Jan 2, 2026Jeff Castelli
Chief Development Officer
FTax withholding
Common Stock
-6,905$14.27$99k432,413Jan 6, 2026
Jan 3, 2026Jeff Castelli
Chief Development Officer
FTax withholding
Common Stock
-23,102$14.27$330k409,311Jan 6, 2026
Jan 3, 2026Samantha Prout
Chief Accounting Officer
FTax withholding
Common Stock
-12,240$14.27$175k125,951Jan 6, 2026
Jan 3, 2026David Michael Clark
Chief People Officer
FTax withholding
Common Stock
-18,498$14.27$264k221,811Jan 6, 2026
Jan 3, 2026Ellen Rosenberg
Chief Legal Officer
FTax withholding
Common Stock
-29,683$14.27$424k464,601Jan 6, 2026
Dec 26, 2025Bradley L Campbell
President and CEO
FTax withholding
Common Stock
-108,602$14.25$1.5M1,021,180Dec 30, 2025
Dec 26, 2025Simon N.R. Harford
Chief Financial Officer
FTax withholding
Common Stock
-71,303$14.25$1.0M143,595Dec 30, 2025
Dec 19, 2025David Michael Clark
Chief People Officer
SOpen-market sale
Common Stock10b5-1
-25,642$14.17$363k245,690Dec 23, 2025
Dec 15, 2025Bradley L Campbell
President and CEO
MOption exercise
Common Stock10b5-1
+70,426$9.03$636k1,207,708Dec 17, 2025
Dec 15, 2025David Michael Clark
Chief People Officer
SOpen-market sale
Common Stock10b5-1
-25,643$11.00$282k271,332Dec 17, 2025
Dec 15, 2025Bradley L Campbell
President and CEO
SOpen-market sale
Common Stock10b5-1
-77,926$10.86$846k1,129,782Dec 17, 2025
Dec 15, 2025Bradley L Campbell
President and CEO
MOption exercise
Stock Options (right to buy)derivative10b5-1
-70,426$0.00$00Dec 17, 2025
Dec 1, 2025Bradley L Campbell
President and CEO
MOption exercise
Common Stock10b5-1
+14,587$9.03$132k1,151,869Dec 3, 2025
Dec 1, 2025Samantha Prout
Chief Accounting Officer
AGrant or award
Common Stock
+32,193$0.00$0141,634Dec 3, 2025
Dec 1, 2025Bradley L Campbell
President and CEO
SOpen-market sale
Common Stock10b5-1
-14,587$10.01$146k1,137,282Dec 3, 2025
Dec 1, 2025Bradley L Campbell
President and CEO
MOption exercise
Stock Options (right to buy)derivative10b5-1
-14,587$0.00$070,426Dec 3, 2025
Nov 24, 2025Bradley L Campbell
President and CEO
MOption exercise
Common Stock10b5-1
+14,587$9.03$132k1,151,869Nov 26, 2025
Nov 24, 2025David Michael Clark
Chief People Officer
SOpen-market sale
Common Stock10b5-1
-25,643$10.10$259k296,975Nov 26, 2025
Nov 24, 2025Jeff Castelli
Chief Development Officer
MOption exercise
Common Stock10b5-1
+50,000$9.03$452k515,476Nov 26, 2025
Nov 24, 2025Ellen Rosenberg
Chief Legal Officer
MOption exercise
Common Stock10b5-1
+25,000$6.10$153k532,710Nov 26, 2025
Nov 24, 2025Bradley L Campbell
President and CEO
SOpen-market sale
Common Stock10b5-1
-14,587$10.04$147k1,137,282Nov 26, 2025
Nov 24, 2025Jeff Castelli
Chief Development Officer
SOpen-market sale
Common Stock10b5-1
-76,158$10.16$774k439,318Nov 26, 2025
Nov 24, 2025Ellen Rosenberg
Chief Legal Officer
MOption exercise
Common Stock10b5-1
+11,000$5.13$56k543,710Nov 26, 2025
Nov 24, 2025Ellen Rosenberg
Chief Legal Officer
SOpen-market sale
Common Stock10b5-1
-36,000$10.06$362k507,710Nov 26, 2025
Nov 24, 2025Bradley L Campbell
President and CEO
MOption exercise
Stock Options (right to buy)derivative10b5-1
-14,587$0.00$085,013Nov 26, 2025
Nov 24, 2025Jeff Castelli
Chief Development Officer
MOption exercise
Stock Options (right to buy)derivative10b5-1
-50,000$0.00$00Nov 26, 2025
Nov 25, 2025Ellen Rosenberg
Chief Legal Officer
MOption exercise
Common Stock10b5-1
+36,000$5.13$185k543,710Nov 26, 2025
Nov 25, 2025Ellen Rosenberg
Chief Legal Officer
SOpen-market sale
Common Stock10b5-1
-36,000$10.00$360k507,710Nov 26, 2025
Nov 26, 2025Ellen Rosenberg
Chief Legal Officer
MOption exercise
Common Stock10b5-1
+23,621$5.13$121k531,331Nov 26, 2025
Nov 26, 2025Ellen Rosenberg
Chief Legal Officer
SOpen-market sale
Common Stock10b5-1
-23,621$10.00$236k507,710Nov 26, 2025
Nov 24, 2025Ellen Rosenberg
Chief Legal Officer
MOption exercise
Stock Options (right to buy)derivative10b5-1
-25,000$0.00$00Nov 26, 2025
Nov 24, 2025Ellen Rosenberg
Chief Legal Officer
MOption exercise
Stock Options (right to buy)derivative10b5-1
-11,000$0.00$059,621Nov 26, 2025
Nov 25, 2025Ellen Rosenberg
Chief Legal Officer
MOption exercise
Stock Options (right to buy)derivative10b5-1
-36,000$0.00$023,621Nov 26, 2025
Nov 26, 2025Ellen Rosenberg
Chief Legal Officer
MOption exercise
Stock Options (right to buy)derivative10b5-1
-23,621$0.00$00Nov 26, 2025
Nov 4, 2025David Michael Clark
Chief People Officer
SOpen-market sale
Common Stock10b5-1
-25,643$9.51$244k322,618Nov 5, 2025
Aug 21, 2025Simon N.R. Harford
Chief Financial Officer
FTax withholding
Common Stock
-12,529$7.60$95k214,898Aug 25, 2025
Jun 5, 2025Lynn Dorsey Bleil
director
AGrant or award
Common Stock
+20,414$0.00$0113,941Jun 6, 2025
Jun 5, 2025Eiry Roberts
director
AGrant or award
Common Stock
+20,414$0.00$076,275Jun 6, 2025
Jun 5, 2025Burke W Whitman
director
AGrant or award
Common Stock
+20,414$0.00$0118,598Jun 6, 2025
Jun 5, 2025Craig A Wheeler
director
AGrant or award
Common Stock
+20,414$0.00$084,631Jun 6, 2025
Jun 5, 2025Michael Aaron Kelly
director
AGrant or award
Common Stock
+20,414$0.00$072,468Jun 6, 2025
Jun 5, 2025Glenn Sblendorio
director
AGrant or award
Common Stock
+20,414$0.00$0115,857Jun 6, 2025
Jun 5, 2025Michael Raab
director
AGrant or award
Common Stock
+20,414$0.00$0115,857Jun 6, 2025
Jun 5, 2025Margaret G McGlynn
director
AGrant or award
Common Stock
+20,414$0.00$091,550Jun 6, 2025
Jun 5, 2025Burke W Whitman
director
AGrant or award
Stock Options (right to buy)derivative
+74,872$0.00$074,872Jun 6, 2025
Jun 5, 2025Craig A Wheeler
director
AGrant or award
Stock Options (right to buy)derivative
+74,872$0.00$074,872Jun 6, 2025
Jun 5, 2025Lynn Dorsey Bleil
director
AGrant or award
Stock Options (right to buy)derivative
+74,872$0.00$074,872Jun 6, 2025
Jun 5, 2025Eiry Roberts
director
AGrant or award
Stock Options (right to buy)derivative
+74,872$0.00$074,872Jun 6, 2025
Jun 5, 2025Michael Aaron Kelly
director
AGrant or award
Stock Options (right to buy)derivative
+74,872$0.00$074,872Jun 6, 2025
Jun 5, 2025Glenn Sblendorio
director
AGrant or award
Stock Options (right to buy)derivative
+74,872$0.00$074,872Jun 6, 2025
Jun 5, 2025Michael Raab
director
AGrant or award
Stock Options (right to buy)derivative
+74,872$0.00$074,872Jun 6, 2025
Jun 5, 2025Margaret G McGlynn
director
AGrant or award
Stock Options (right to buy)derivative
+74,872$0.00$074,872Jun 6, 2025
Mar 15, 2025Bradley L Campbell
President and CEO
FTax withholding
Common Stock
-13,375$8.90$119k1,137,282Mar 18, 2025
Feb 19, 2025Bradley L Campbell
President and CEO
MOption exercise
Common Stock10b5-1
+400$9.03$3,6121,151,057Feb 21, 2025
Feb 19, 2025Bradley L Campbell
President and CEO
SOpen-market sale
Common Stock10b5-1
-400$10.00$4,0001,150,657Feb 21, 2025
Feb 19, 2025Bradley L Campbell
President and CEO
MOption exercise
Stock Options (right to buy)derivative10b5-1
-400$0.00$099,600Feb 21, 2025
Feb 11, 2025Ellen Rosenberg
Chief Legal Officer
AGrant or award
Common Stock
+64,800$0.00$0536,294Feb 13, 2025
Feb 11, 2025Bradley L Campbell
President and CEO
AGrant or award
Common Stock
+137,075$0.00$01,220,768Feb 13, 2025
Feb 11, 2025David Michael Clark
Chief People Officer
AGrant or award
Common Stock
+52,338$0.00$0368,854Feb 13, 2025
Feb 11, 2025Jeff Castelli
Chief Development Officer
AGrant or award
Common Stock
+52,338$0.00$0488,200Feb 13, 2025
Feb 11, 2025Samantha Prout
Chief Accounting Officer
AGrant or award
Common Stock
+27,416$0.00$0122,941Feb 13, 2025
Feb 11, 2025Ellen Rosenberg
Chief Legal Officer
FTax withholding
Common Stock
-28,584$9.57$274k507,710Feb 13, 2025
Feb 11, 2025Bradley L Campbell
President and CEO
FTax withholding
Common Stock
-70,711$9.57$677k1,150,657Feb 13, 2025
Feb 11, 2025David Michael Clark
Chief People Officer
FTax withholding
Common Stock
-20,593$9.57$197k348,261Feb 13, 2025
Feb 11, 2025Jeff Castelli
Chief Development Officer
FTax withholding
Common Stock
-22,724$9.57$217k465,476Feb 13, 2025
Feb 11, 2025Samantha Prout
Chief Accounting Officer
FTax withholding
Common Stock
-13,500$9.57$129k109,441Feb 13, 2025
Jan 2, 2025Simon N.R. Harford
Chief Financial Officer
FTax withholding
Common Stock
-7,482$9.31$70k144,354Jan 6, 2025
Jan 2, 2025Jeff Castelli
Chief Development Officer
FTax withholding
Common Stock
-6,990$9.31$65k370,215Jan 6, 2025
Jan 2, 2025Ellen Rosenberg
Chief Legal Officer
FTax withholding
Common Stock
-6,442$9.31$60k377,777Jan 6, 2025
Jan 2, 2025Bradley L Campbell
President and CEO
FTax withholding
Common Stock
-20,647$9.31$192k866,007Jan 6, 2025
Jan 2, 2025David Michael Clark
Chief People Officer
FTax withholding
Common Stock
-5,381$9.31$50k261,967Jan 6, 2025
Jan 2, 2025Samantha Prout
Chief Accounting Officer
FTax withholding
Common Stock
-3,443$9.31$32k70,483Jan 6, 2025
Jan 3, 2025Simon N.R. Harford
Chief Financial Officer
AGrant or award
Common Stock
+83,073$0.00$0227,427Jan 6, 2025
Jan 3, 2025Jeff Castelli
Chief Development Officer
AGrant or award
Common Stock
+83,073$0.00$0453,288Jan 6, 2025
Jan 3, 2025Bradley L Campbell
President and CEO
AGrant or award
Common Stock
+266,528$0.00$01,132,535Jan 6, 2025
Jan 3, 2025David Michael Clark
Chief People Officer
AGrant or award
Common Stock
+69,228$0.00$0331,195Jan 6, 2025
Jan 3, 2025Samantha Prout
Chief Accounting Officer
AGrant or award
Common Stock
+34,614$0.00$0105,097Jan 6, 2025
Jan 3, 2025Ellen Rosenberg
Chief Legal Officer
AGrant or award
Common Stock
+112,495$0.00$0490,272Jan 6, 2025
Jan 3, 2025Simon N.R. Harford
Chief Financial Officer
AGrant or award
Stock Options (right to buy)derivative
+150,517$0.00$0150,517Jan 6, 2025
Jan 3, 2025Jeff Castelli
Chief Development Officer
FTax withholding
Common Stock
-14,299$9.41$135k438,989Jan 6, 2025
Jan 3, 2025Bradley L Campbell
President and CEO
FTax withholding
Common Stock
-41,474$9.41$390k1,091,061Jan 6, 2025
Jan 3, 2025David Michael Clark
Chief People Officer
FTax withholding
Common Stock
-11,987$9.41$113k319,208Jan 6, 2025
Jan 3, 2025Samantha Prout
Chief Accounting Officer
FTax withholding
Common Stock
-8,275$9.41$78k96,822Jan 6, 2025
Jan 3, 2025Ellen Rosenberg
Chief Legal Officer
FTax withholding
Common Stock
-15,397$9.41$145k474,875Jan 6, 2025
Jan 4, 2025Jeff Castelli
Chief Development Officer
FTax withholding
Common Stock
-3,127$9.41$29k435,862Jan 6, 2025
Jan 4, 2025Bradley L Campbell
President and CEO
FTax withholding
Common Stock
-7,368$9.41$69k1,083,693Jan 6, 2025
Jan 4, 2025David Michael Clark
Chief People Officer
FTax withholding
Common Stock
-2,692$9.41$25k316,516Jan 6, 2025
Jan 4, 2025Samantha Prout
Chief Accounting Officer
FTax withholding
Common Stock
-1,297$9.41$12k95,525Jan 6, 2025
Jan 4, 2025Ellen Rosenberg
Chief Legal Officer
FTax withholding
Common Stock
-3,381$9.41$32k471,494Jan 6, 2025
Jan 3, 2025Jeff Castelli
Chief Development Officer
AGrant or award
Stock Options (right to buy)derivative
+150,517$0.00$0150,517Jan 6, 2025
Jan 3, 2025Bradley L Campbell
President and CEO
AGrant or award
Stock Options (right to buy)derivative
+482,908$0.00$0482,908Jan 6, 2025
Jan 3, 2025David Michael Clark
Chief People Officer
AGrant or award
Stock Options (right to buy)derivative
+125,430$0.00$0125,430Jan 6, 2025
Jan 3, 2025Samantha Prout
Chief Accounting Officer
AGrant or award
Stock Options (right to buy)derivative
+62,715$0.00$062,715Jan 6, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

FOLD insider trading: AMICUS THERAPEUTICS, INC. | InsiderTell